12:00 AM
 | 
Aug 28, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Veldona oral low dose natural interferon-alpha regulatory update

The FDA granted Orphan Drug designation for Veldona to treat papillomavirus mouth warts in HIV positive...

Read the full 58 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >